Related Experiment Video
Updated: Mar 24, 2026
05:08
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
1.3K
Palaeopathology: Current challenges and medical impact
Frank J Rühli1, Francesco M Galassi2, Martin Haeusler2,3
1Institute of Evolutionary Medicine (IEM), University of Zurich, Winterthurerstrasse 190, Zurich, Switzerland. frank.ruehli@iem.uzh.ch.
Clinical Anatomy (New York, N.Y.)
|March 5, 2016
Summary
Palaeopathology, the study of ancient diseases, has advanced significantly with new technologies. These advancements enhance our understanding of past health and disease, contributing to modern medical research.
Area of Science:
- Paleopathology
- Paleo-medicine
- Medical History
Background:
- Palaeopathology has evolved significantly through technological advancements, from morphology to CT scanning.
- The discipline studies ancient human diseases, including findings in mummies and fossilized hominids.
- Research spans basic science, individual cases, and population studies, with pathography emerging as a sub-specialty.
Purpose of the Study:
- To review the advancements and contributions of palaeopathology.
- To address the challenges in scientific recognition within the clinical community.
- To propose strategies for strengthening the discipline's impact on medical research.
Main Methods:
- Review of technological advancements in palaeopathology.
- Analysis of research levels: basic, individual cases, and population studies.
- Exploration of pathography's interdisciplinary approach.
Main Results:
- Palaeopathology has successfully extracted ancient DNA, identified ancient atherosclerosis, and documented spine pathology in hominids.
- Technological progress has clarified the etiology of infectious diseases and identified disease vectors.
- Despite discoveries, some outdated techniques limit full clinical acceptance.
Conclusions:
- Palaeopathology offers valuable insights into disease evolution and etiology.
- Strengthening scientific recognition requires addressing technical limitations and promoting interdisciplinary approaches.
- The discipline holds significant potential to contribute to the progress of medical research.
More Related Videos
Related Concept Videos
01:28Fungal Phylum Microsporidia
695
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
695
01:14Changes in Skin Color: Clinical Perspectives
4.1K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.1K
01:29Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
02:18The Proteasome
10.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.5K